TY - JOUR
T1 - Infantile acropustulosis revisited
T2 - History of scabies and response to topical corticosteroids
AU - Mancini, Anthony J.
AU - Frieden, Ilona J.
AU - Paller, Amy S.
PY - 1998/9/1
Y1 - 1998/9/1
N2 - Infantile acropustulosis (IA) is a condition of young children characterized by recurrent episodes of pruritic vesicles and pustules in an acral distribution. Several reports describe patients with scabies infestation prior to the diagnosis of IA, although the relationship between the two remains unclear. Furthermore, optimal therapy is controversial. We reviewed the history of scabies and response to therapy in 21 patients diagnosed with IA at two institutions between 1.983 and 1997. A history of prior treatment for scabies was noted in 14 patients, although only two had mites, feces, or ova detected on microscopic examination for diagnostic verification. All patients were treated with topical corticosteroids (4 with class I, 12 with class II, 3 with class III, 1 with class IV, and I with class VI). All 18 patients who returned for follow-up experienced significant improvement or cleared completely with treatment. There were no observed cutaneous or systemic side effects from corticosteroid therapy. We conclude that a history of preceding scabies is common in patients with IA, but often this diagnosis is made without microscopic confirmation. We also demonstrate that mid- to high-potency topical corticosteroids are a safe and effective first-line therapy for patients with IA.
AB - Infantile acropustulosis (IA) is a condition of young children characterized by recurrent episodes of pruritic vesicles and pustules in an acral distribution. Several reports describe patients with scabies infestation prior to the diagnosis of IA, although the relationship between the two remains unclear. Furthermore, optimal therapy is controversial. We reviewed the history of scabies and response to therapy in 21 patients diagnosed with IA at two institutions between 1.983 and 1997. A history of prior treatment for scabies was noted in 14 patients, although only two had mites, feces, or ova detected on microscopic examination for diagnostic verification. All patients were treated with topical corticosteroids (4 with class I, 12 with class II, 3 with class III, 1 with class IV, and I with class VI). All 18 patients who returned for follow-up experienced significant improvement or cleared completely with treatment. There were no observed cutaneous or systemic side effects from corticosteroid therapy. We conclude that a history of preceding scabies is common in patients with IA, but often this diagnosis is made without microscopic confirmation. We also demonstrate that mid- to high-potency topical corticosteroids are a safe and effective first-line therapy for patients with IA.
UR - http://www.scopus.com/inward/record.url?scp=0031715201&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031715201&partnerID=8YFLogxK
U2 - 10.1046/j.1525-1470.1998.1998015337.x
DO - 10.1046/j.1525-1470.1998.1998015337.x
M3 - Article
C2 - 9796580
AN - SCOPUS:0031715201
SN - 0736-8046
VL - 15
SP - 337
EP - 341
JO - Pediatric dermatology
JF - Pediatric dermatology
IS - 5
ER -